| 1149 |
English |
Replacement Sequence in the H Mono/Poly DR-TB and Shorter Oral Bdq-containing MDR/RR-TB Regimens |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1151 |
English |
Use of Isoniazid [H] Mono/Poly DR-TB Regimen in Special Situations |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1122 |
English |
TB Preventive Treatment [TPT]: Follow-up Monitoring for Contacts of DR-TB Index Patients |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1123 |
English |
TB Preventive Treatment [TPT]: Treatment Adherence for Contacts of DR-TB Index Patients |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1125 |
English |
Newer Anti-TB Drugs |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1126 |
English |
Newer Anti-TB Drugs: Bedaquiline [Bdq] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1048 |
English |
Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1049 |
English |
DR-TB Treatment in Pregnancy: General Considerations |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1050 |
English |
Immune Reconstitution Inflammatory Syndrome [IRIS] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1051 |
English |
Common or Relevant Adverse Effects of DR-TB Therapy |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1052 |
English |
Management of QT Prolongation by Grade of Severity of ADR |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1053 |
English |
Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1054 |
English |
State PMDT Committee: Terms of Reference [ToR] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1055 |
English |
State Airborne Infection Control [AIC] Committee: Terms of Reference [ToR] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1056 |
English |
Management of Hepato-toxicity During Treatment with H Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1071 |
English |
State Airborne Infection Control [AIC] Committee |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1072 |
English |
Requirements for Establishing District DR-TB Centres |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1073 |
English |
Functions of District DR-TB Centre |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1074 |
English |
Mandatory Establishment of DR-TB Centres in All Medical Colleges |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1075 |
English |
Drug-resistant TB Service Linkages to Private Sectors |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1076 |
English |
Weight Band-wise Dosages of DR-TB Drugs for Adults |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1029 |
English |
Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1030 |
English |
Bedaquiline Drug Dosages and Duration |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1031 |
English |
Eligibility Criteria for the Use of Delamanid [Dlm] in MDR/RR-TB Treatment |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1032 |
English |
Delamanid [Dlm] Drug Dosages and Duration |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1035 |
English |
Components of Drug Resistant TB Counselling Tool |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1036 |
English |
Key Messages for TB Counselling |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1038 |
English |
Pre-treatment Evaluation [PTE] of DR-TB Patients |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1016 |
English |
Constituents of Patient-wise Boxes [PWB] for Isoniazid [H] Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1017 |
English |
Guidelines for Issuing Bedaquiline and Delamanid to the Patient |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1018 |
English |
Role of the State Drug Store [SDS] in the Constitution of Patient-wise Boxes |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1026 |
English |
Drugs Used in the Management of Adverse Events |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1027 |
English |
Rationale for Grouping of Anti-TB Drugs |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1028 |
English |
Drugs Not Included in Groups A - C and Rationale for Non-inclusion |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 981 |
English |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Special Situations |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 982 |
English |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 985 |
English |
Eligibility Criteria for Longer Oral M/XDR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 986 |
English |
Treatment Extension in Isoniazid [H] Mono/Poly DR-TB Regimen |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1000 |
English |
Management of DR-TB ADR: Gastrointestinal Symptoms [Gastritis and abdominal pain] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1001 |
English |
Management of DR-TB ADR: Diarrhoea and/or Flatulence |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1002 |
English |
Management of DR-TB ADR: Giddiness |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
| 1003 |
English |
Management of DR-TB ADR: Hematological Abnormalities |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1004 |
English |
Management of DR-TB ADR: Hypothyroidism |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1005 |
English |
Management of DR-TB ADR: Arthralgia |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1006 |
English |
Management of DR-TB ADR: Depression |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1007 |
English |
Management of DR-TB ADR: Psychotic Symptoms |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1008 |
English |
Management of DR-TB ADR: Suicidal Ideation |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1009 |
English |
Management of DR-TB ADR: Seizures |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1010 |
English |
Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
| 1011 |
English |
Management of DR-TB ADR: Gynecomastia |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
